Professor
Jonathan Ledermann (CRUK Cancer Trials Centre at UCL) said: "While today's
decision by NICE will be welcomed by all those involved in treating and
supporting women with this disease, it is disappointing that the decision has
taken so long and some will still not have access".
Read: Daily Mail
Close
